InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Discover the detailed record of transactions filed by Rich Tyvin. Director active across 1 company, notably Shuttle Pharmaceuticals Holdings, Inc.. Cumulatively, 1 reports have been published. Split: 0 buy · 1 sell. Total volume traded: €2k. Activity tracked since 29 December 2022. The latest transaction was filed on 29 December 2022 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
1 of 1 declaration